Vivos Therapeutics, Inc. VVOS
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.77M | 2.11M | 2.03M | 3.09M | 4.40M |
| Total Receivables | 1.44M | 1.77M | 1.58M | 2.13M | 1.63M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.00M | 940.00K | 774.00K | 565.00K | 695.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.21M | 4.82M | 4.38M | 5.79M | 6.73M |
|
|
|||||
| Total Current Assets | 4.21M | 4.82M | 4.38M | 5.79M | 6.73M |
| Net Property, Plant & Equipment | 7.45M | 7.56M | 7.92M | 9.03M | 8.37M |
| Long-term Investments | 8.57M | 8.57M | 8.57M | 8.45M | 8.45M |
| Goodwill | 8.57M | 8.57M | 8.57M | 8.45M | 8.45M |
| Total Other Intangibles | 3.64M | 3.84M | 4.05M | 2.17M | 2.23M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 272.00K | 254.00K | 228.00K | 211.00K | 255.00K |
| Total Assets | 24.14M | 25.04M | 25.15M | 25.64M | 26.03M |
|
|
|||||
| Total Accounts Payable | 2.95M | 2.00M | 1.68M | 2.10M | 1.76M |
| Total Accrued Expenses | 7.04M | 6.11M | 5.99M | 2.68M | 2.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.62M | 8.10M | 9.08M | 1.13M | 866.00K |
| Total Finance Division Other Current Liabilities | 1.78M | 1.73M | 1.33M | 1.52M | 1.50M |
| Total Other Current Liabilities | 1.78M | 1.73M | 1.33M | 1.52M | 1.50M |
| Total Current Liabilities | 20.39M | 17.94M | 18.08M | 7.44M | 6.43M |
|
|
|||||
| Total Current Liabilities | 20.39M | 17.94M | 18.08M | 7.44M | 6.43M |
| Long-Term Debt | 366.00K | 418.00K | 469.00K | 8.38M | 7.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.52M | 3.75M | 3.95M | 2.99M | 2.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.85M | 4.20M | 4.20M | 4.31M | 4.31M |
| Total Liabilities | 28.13M | 26.31M | 26.70M | 23.11M | 21.45M |
|
|
|||||
| Common Stock & APIC | 133.60M | 131.90M | 123.87M | 121.00M | 117.65M |
| Retained Earnings | -138.52M | -133.04M | -125.36M | -118.46M | -113.06M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4.92M | -1.14M | -1.49M | 2.53M | 4.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | 1.11M | -- | -- | -- | -- |
| Total Preferred Equity | 1.11M | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.92M | -1.14M | -1.49M | 2.53M | 4.58M |
| Total Preferred Equity | 1.11M | -- | -- | -- | -- |
| Total Minority Interest | -171.00K | -129.00K | -60.00K | -- | -- |
| Total Equity | -3.99M | -1.27M | -1.55M | 2.53M | 4.58M |
|
|
|||||